European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Importantly, each site features advanced technologies to support development and manufacture of these therapeutics. Materials and financing costs are high and squeezing manufacturers and their customers alike.

Pharmaceutical manufacturing 86

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 86

Pharmaceutical Technology

MAY 17, 2023

WuXi Biologics and InflaRx have entered a manufacturing partnership for advancing Gohibic (vilobelimab) to treat certain critically ill Covid-19 patients. Under the collaboration, WuXi Biologics will be responsible for providing cGMP manufacturing of Gohibic.

Manufacturing 52

Manufacturing Food and Drug Administration Networking FDA 52

European Pharmaceutical Review

MARCH 23, 2023

Through its investment of approximately £600 million, Takeda plans to build a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. This is Takeda’s largest ever investment in manufacturing capacity expansion and will be the largest facility of its kind in Japan.

Manufacturing 63

Manufacturing Networking Medicine Medical 63

Pharmaceutical Technology

MARCH 24, 2023

Takeda has unveiled plans to invest almost $764m (JPY100bn) to construct a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. The new facility represents the company’s largest-ever investment in the expansion of manufacturing capacity in the country.

Manufacturing 52

Manufacturing Networking Patients Pharma 52

Legacy MEDSearch

DECEMBER 21, 2022

a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the “ALICE device”) to undergo the Verification and Validation phase prior to its planned 2023 submission to the U.S. Inspira Technologies OXY B.H.N. and Israel.

Manufacturing 98

Manufacturing FDA Food and Drug Administration Medical 98

Pharmaceutical Technology

AUGUST 17, 2022

Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. It will also have the potential to scale to Phase III clinical development and commercial manufacturing.

Manufacturing 52

Manufacturing Networking Media Engineering 52

European Pharmaceutical Review

NOVEMBER 8, 2022

Sandoz , a leading antibiotics producer has announced its €50 million investment to increase Europe’s manufacturing capacity of finished dosage form (FDF) penicillin, the most common form of antibiotic worldwide, to enhance global manufacturing capacity of amoxicillin and other major penicillin products.

Manufacturing 52

Manufacturing Networking Pharmaceutical Medicine 52

European Pharmaceutical Review

APRIL 4, 2024

Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. The funding will start with three established Centres, and then across an expanded network, according to Chief Clinical Officer for Cell and Gene Therapy Catapult, Jacqueline Barry.

Networking 86

Networking Training Recruitment Healthcare 86

Pharmaceutical Technology

SEPTEMBER 7, 2022

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.

Leads 52

Leads Pharmaceutical Patients Pharmaceutical manufacturing 52

PM360

SEPTEMBER 15, 2022

PM360 asked industry experts what it takes to be a patient-first organization and how companies can better ensure they are delivering experiences that meet patients’ expectations. Specifically, we asked them: What is required today for life sciences companies to truly practice a patient-first approach? Matt Flesch.

Patients 98

Patients Education Management Side effects 98

Impetus Digital

JANUARY 30, 2023

Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.

Pharmaceutical 68

Pharmaceutical Patients Safety Distribution 68

European Pharmaceutical Review

NOVEMBER 23, 2022

The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU).

Medicine 100

Medicine Networking Manufacturing Training 100

European Pharmaceutical Review

FEBRUARY 9, 2024

Under the terms of the agreement, BioNTech will pay $50 million to Autolus, granting the immunotherapy company rights including the option to access Autolus’ commercial and clinical site network, manufacturing capacities in the UK and commercial supply infrastructure.

Networking 102

Networking Manufacturing Sales Leads 102

Legacy MEDSearch

MARCH 14, 2023

The report concluded that the Company’s UroShield device showed a decrease in the number of blockages and infections and an increase in catheter satisfaction in the patients studied. UroShield is available to all NHS clinicians and their patients who need the device with full clinical support, through the NHS supply chain.

Patients 98

Patients Medical Recruitment Management 98

European Pharmaceutical Review

OCTOBER 2, 2023

Uniting the global supply chain CPHI Barcelona serves as a vital platform for unrivalled networks and access to the global supply chain. The market space offers various benefits, including promotion as a show feature, access to start-up mentors, and a dedicated start-up networking lounge. Manufacturing Excellence 5.

Manufacturing 98

Manufacturing Pharma Engineering Networking 98

European Pharmaceutical Review

DECEMBER 7, 2023

A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.

Networking 85

Networking Medicine Leads Manufacturing 85

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patients 86

Patients Pharma Consulting Transportation 86

Pharmaceutical Technology

NOVEMBER 7, 2022

SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. Currently, SHL Medical has four locations, in Switzerland, Taiwan, Sweden, and the US, with Taiwan being the main manufacturing location. Growing demand for patient independence.

Medical 52

Medical Patients Transportation Manufacturing 52

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

pharmaphorum

JANUARY 22, 2023

A well-designed and thought-out digital solution, with a considered user experience, can deliver a better service and support HCPs to deliver positive patient outcomes, whilst strengthening relationships between pharma companies and their HCP networks. How can this impact patient care? What is meant by an HCP portal?

Pharma 91

Pharma Patients Marketing Distribution 91

European Pharmaceutical Review

MAY 2, 2024

This was compared to patients who received no intervention. Beyfortus approved for US infants against RSV disease The post Long-acting antibody demonstrates promising efficacy in infant RSV appeared first on European Pharmaceutical Review.

Manufacturing 106

Manufacturing Government Networking Pharmaceutical 106

European Pharmaceutical Review

JUNE 13, 2023

ITM Isotope Technologies Munich SE ( ITM )’s manufacturing plant in Neufahrn near Munich will produce the innovative medical isotope for targeted cancer therapies. “Radiopharmaceuticals are an essential new class of anti-cancer drugs that have the potential to improve therapy outcomes and quality of life for many patients.

Manufacturing 95

Manufacturing Networking Medical Pharma 95

European Pharmaceutical Review

MAY 22, 2024

WHO confirmed that the newly approved WLAs include: The European Medicines Regulatory Network (EMRN), which is made up of the European Commission (EC), the European Medicines Agency (EMA) and the medicines regulatory authorities of 30 countries.

Medicine 68

Medicine Leads Food and Drug Administration Safety 68

European Pharmaceutical Review

AUGUST 15, 2023

The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region. “We expect a large international attendance and will marry this with local and regional manufacturing insights.”

Manufacturing 90

Manufacturing Pharma Pharmaceutical Pharmaceutical research 90

European Pharmaceutical Review

AUGUST 31, 2023

Cancer patients critically depend on accurate diagnosis and disease treatment. By reaching cancer cells that have already spread throughout the body, a targeted radiopharmaceutical treatment offers an alternative for patients with advanced cancer when standard lines of treatment, such as chemotherapy, have failed.

Food and Drug Administration 79

Food and Drug Administration Manufacturing Safety Transportation 79

Pharmaceutical Technology

MAY 18, 2023

Within the 14-page document , published by an EMA special task force, are 10 recommendations of best practices that “marketing authorisation holders, wholesalers, distributors, and manufacturers can consider adopting to ensure continuity of medicinal product supply and reduce the impact of shortages”.

Medicine 99

Medicine Specialization Networking Patients 99

European Pharmaceutical Review

APRIL 4, 2024

US radiopharmacy network RLS Radiopharmacies is expanding its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by establishing a partnership with global isotope technology company Eckert & Ziegler.

Transportation 81

Transportation Distribution Healthcare Healthcare 81

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. Innovent Biologics, a domestic manufacturer, is currently evaluating its anti-diabetic and weight-loss GLP-1 drug, mazdutide, in a phase 3 trial in Mainland China, backed by Eli Lilly.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

European Pharmaceutical Review

APRIL 2, 2024

At Roche, we see it as our ethical and environmental responsibility to support the use of alternative methods that prioritise animal welfare while ensuring the safety of our patients and the quality of our products. However, for companies that manufacture globally marketed products, the journey towards implementing rFC is a slow one.

Ethics 89

Ethics Manufacturing Marketing Networking 89

Legacy MEDSearch

AUGUST 9, 2023

Given the risks associated with open heart surgeries, many patients delay treatment, unwittingly increasing their health risks as well as the chances they may be too weak later on for open heart surgery. This technique speeds recovery from months to weeks and is likely tolerable for even the sickest of patients. venture capital firm.

Medical 52

Medical Patients Recruitment Engineering 52

European Pharmaceutical Review

MAY 26, 2023

These positive steps will put us on the front-foot in the global race to develop and manufacture the next generation of medicines and technologies.” Manufacturing The manufacturing arm of the UK’s life sciences sector is also set for a funding boost thanks to three new pots to bolster the country’s health resilience.

Manufacturing 101

Manufacturing Medicine Pharmaceutical Networking 101

Pharmaceutical Technology

MAY 24, 2023

The ability to modify or introduce genetic material in human cells in such a precise and patient-centered manner clearly constitutes a breakthrough in personalized medicine. Allogeneic therapies begin with healthy donor samples to develop the eventual therapeutic product which can be administered to multiple patients.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

European Pharmaceutical Review

SEPTEMBER 25, 2023

ERP systems and drug serialisation As the scale of generating serialising products is minimal, small manufacturers can alter or improve their current Base ERP system and develop an internal serialisation process. This can be measured by success factors of systems that have been successfully implemented and their interactions.”

Pharmaceutical 94

Pharmaceutical Pharmacology Safety Manufacturing 94

Pharmaceutical Technology

MAY 22, 2023

Thermo Fisher Scientific has expanded its sterile manufacturing and research capabilities in the Asia-Pacific region with the opening of a new sterile drug facility in Singapore. The new good manufacturing practices facility was established with support from the Singapore Economic Development Board.

Manufacturing 59

Manufacturing Networking Medicine Pharmaceutical 59

pharmaphorum

JANUARY 4, 2023

Often referred to as “off-the-shelf,” allogeneic cell therapies are derived from a single source of donor cells, cultured, and expanded, and then used to treat many patients. A single large batch of engineered cells can potentially treat hundreds of patients. The approval represents a significant moment for the CGT industry.

Transportation 96

Transportation Manufacturing Patients Networking 96

Pharmaceutical Technology

APRIL 27, 2023

With multi-product, in-house viral vector production capabilities, the new facility in Libertyville, Illinois, US, is expected to strengthen the company’s long-term viral vector supply and advance its long-term goals and global manufacturing network in cell therapy. The new facility will be handed over to Bristol Myers Squibb in 2023.

Engineering 52

Engineering Manufacturing Networking Medicine 52

Pharma Marketing Network

JULY 27, 2023

Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceutical companies, and medical device manufacturers alike. These partnerships not only improve patient outcomes but also foster mutual trust and collaboration.

Ethics 98

Ethics Education Healthcare Healthcare 98